CD4 and cancer: To ascertain if the molecular changes took place in cancer cells or in the infiltrating immune cells, we performed experiments using tumor cell suspensions depleted of the main infiltrating immune cell subsets, namely CD4+ and CD8+ T lymphocytes and macrophages (19, 50, 51).